Monthly Archives: June 2021

Creature From The Black Wuhan

June 2, 2021 By in Biotech, IBB, MRNA, SPBIO

1:04 p.m., EST

How long will this side-show last?

Once you’re awake, diversions like this one, have no effect.

Well, none almost, other than to be reminded the powers that be have absolute contempt for those that aren’t in their global club.

You have to wonder, what’s next? Maybe it’s time for the (fake, or real) alien invasion.

Maybe we’ll have a few more ‘planned’ cyber attacks … who knows?

Meanwhile, back at the ranch, it’s more than a bit interesting the biotech sector with its quarterly reversal, weak 23.6% retrace, and now continuing downside (so far), is not a major topic of discussion.

This morning, Moderna’s (MRNA) attempting a breakout. It won’t look so good if it can’t close higher for the day.

The last update showed MRNA, insiders bailing out.

SPBIO looks to be establishing or confirming a downside trend-line. More on that if/when there’s confirmation.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

.

‘The Race’

June 1, 2021 By in Biotech, LABD, SPBIO, The Speck

10:26 a.m., EST

The Race To The Fall

No, it’s not a race to full ‘injection’ as the article at this link implies.

It’s a race to have as many immune systems compromised (destroyed, probably more accurate) before the regular flu season.

If the alternate data (more on that below) is even half-right, that’s when the real effects kick in.

Of course, anyone still watching mainstream outlets will be led to believe it’s some kind of ‘triple mutant variant’, that requires a ‘booster’.

It’s as ridiculous as ‘Double secret probation‘

There’s an entire segment (possibly, a majority) of the world population that would suffer a mental collapse if they discovered the truth.

Instead of searching for truth, they grab the jack-boot (of injection) ever more tightly in a vain psychotic hope their executioner will spare them.

That sentiment is supported by reports of second injections … even after the fist one is nearly fatal.

Which brings us to the biotech sector.

Analysis:

In the first thirty minutes of trading, we can see SPBIO, has made a new daily low with inverse LABD (below), making a new daily high.

That price action helps confirm (no guarantee) that we’ve pivoted at the 23.6%, level as discussed earlier in this update.

If SPBIO continues to erode from here, it’s indicating potential for a sustained, possibly dramatic move lower.

If the reports found on alternate sites (here and here) are true, biotech is destroying its own customer base; most of that base may be gone by the end of the year:

The ‘race to the fall’, indeed.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.